Non-AS | AS | P for interaction* | |||||||
---|---|---|---|---|---|---|---|---|---|
Intensive treatment | Standard treatment | Hazard ratio (95% CI) | P value | Intensive treatment | Standard treatment | Hazard ratio (95% CI) | P value | ||
N | 1980 | 1838 | 1464 | 1583 | |||||
Primary outcomea, n (%) | 48 (2.42) | 69 (3.75) | 0.63 (0.43–0.92) | 0.02 | 55 (3.76) | 76 (4.80) | 0.76 (0.54–1.09) | 0.13 | 0.43 |
Stroke, n (%) | 12 (0.61) | 23 (1.25) | 0.48 (0.23–0.99) | 0.05 | 19 (1.30) | 35 (2.21) | 0.58 (0.33–1.02) | 0.06 | 0.68 |
MACEb, n (%) | 36 (1.82) | 51 (2.77) | 0.62 (0.39–0.97) | 0.04 | 37 (2.53) | 46 (2.91) | 0.83 (0.53–1.29) | 0.40 | 0.34 |
ACS, n (%) | 21 (1.06) | 29 (1.58) | 0.66 (0.39–1.19) | 0.17 | 21 (1.43) | 26 (1.64) | 0.87 (0.48–1.58) | 0.66 | 0.52 |
Death from any causes, n (%) | 21 (1.06) | 14 (0.76) | 1.41 (0.71–2.78) | 0.33 | 22 (1.50) | 24 (1.52) | 0.98 (0.55–1.76) | 0.96 | 0.48 |